Hjem › Prostatakreft › Texas › Fort Worth
Kliniske studier for Prostatakreft i Fort Worth, TX
9 studier for Prostatakreft søker deltakere på steder i og rundt Fort Worth (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekruttererFase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekruttererFase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruttererFase 3
- University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- START Dallas-Fort Worth, Fort Worth
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
RekruttererFase 3
- Urology Partners of North Texas (UPNT), Fort Worth
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruttererFase 3
- Tarrant County Hospital District/JPS Health Network, Fort Worth
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RekruttererFase 1
- START Dallas, Fort Worth
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruttererFase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Fort Worth
- Ikke-småcellet lungekreft18 studier
- Eggstokkreft17 studier
- Endometriekreft12 studier
- Brystkreft11 studier
- Kreft (alle typer)9 studier
- Hjertesvikt7 studier
- Kolorektal kreft7 studier
- Tripelnegativ brystkreft7 studier
- Metastatisk kreft7 studier
- Nyrekreft (nyrecellekarcinom)7 studier
- Ulcerøs kolitt7 studier
- Makuladegenerasjon7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.